跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Nasathera CPM - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Nasathera CPM
Approved
STANDARD
Nasathera CPM
Morishita-Seggs Pharmaceuticals, Inc.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
95cfdec78d98c86b
Company
Morishita-Seggs Pharmaceuticals, Inc.
Type
Standard
Approval Details
Approval Id
95cfdec78d98c86b
Drug Approval Philippines Name
Nasathera CPM
Product Name
Nasathera CPM
Registration Number
DR-XY44499
Brand Name
Nasathera CPM
Generic Name
Paracetamol + Phenylpropanolamine (As Hydrochloride)+ Chlorphenamine Maleate
Dosage Form
Capsule
Dosage Strength
325mg/25mg/2mg
Manufacturer
Morishita-Seggs Pharmaceuticals, Inc.
Importer
Oxford Distributions Incorporated
Distributor
Oxford Distributions Incorporated
Issuance Date
25 June 2021
Expiry Date
04 November 2026
Classification
Over-the-Counter (OTC) Drug
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
95cfdec78d98c86b
Type
Standard
Back to Philippines FDA Approvals